CoChat

Bile Acids Activated Receptors in Inflammatory Bowel Disease

Open access

The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.

Abstract

Once known exclusively for their role in nutrients absorption, bile acids have emerged as signaling molecules, generated from cholesterol breakdown, acting on several immune cells by activating a variety of receptors including the G protein-coupled bile acid receptor 1 (GPABR1 or TGR5), the Farnesoid-X-receptor (FXR) and, as recently discovered, the retinoid-related orphan receptors (ROR)γt. GPBAR1, FXR, and RORγt are highly expressed in cells of the innate and adaptive immune system (i.e., dendritic cells (DCs), macrophages, innate lymphoid 3 cells (ILC3s), and T helper 17 (Th17) lymphocytes) and plays an important role in regulating intestinal and liver immunity, highlighting a role for various bile acid species in regulating immune responses to intestinal microbial antigens. While primary bile acids are generated from the cholesterol breakdown secondary bile acids, the GPBAR1 ligands, and oxo-bile acids derivatives, the RORγt ligands, are generated by the intestinal microbiota, highlighting the potential of these bile acids in mediating the chemical communication between the intestinal microbiota and the host. Changes in intestinal microbiota, dysbiosis, alter the composition of the bile acid pool, promoting the activation of the immune system and development of chronic inflammation. In this review, we focus on the molecular mechanisms by which an altered bile acid signaling promotes intestinal inflammation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells10061281

Cites

108 of 108 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Microbiota, bile acid pool, and regulation of intestinal immunity. In a healthy condition, the majority of bile acids are actively reabsorbed by the enterocytes by apical transporter ASBT, and are transported back to the liver through the portal blood, thus limiting BA loss through feces to 3%–5% of daily secreted BAs. BAs reaching the colon are metabolized by the intestinal microbiota which transforms primary bile acids into secondary bile acids and other derivatives which therefore make up the majority of the bile acid pool. BAs through agonism on FXR and GPBAR1 and antagonism on RORγt (inverse agonism) regulate the immune system by inducing a tolerogenic response. The action on these receptors induces the polarization of macrophages and helper T cells towards an anti-inflammatory phenotype, respectively macrophages M2 and Treg, with the up-regulation of IL-10 production, and inhibits the activation of DCs, ILC3, and Th17 by reducing the production of pro-inflammatory cytokines (i.e., IL-6, IL-1β, TNF-α, and IL-17). In patients with IBDs, the alterations of the intestinal epithelium reduce the reabsorption of bile acids and therefore increase the quantity of bile acids that are eliminated with the feces. Furthermore, patients with IBDs have a dysbiosis of the intestinal bacterial flora with a decrease in bacterial species diversity, which strongly decreases the enzymatic capacity of the microbiota, resulting in a lower ability to metabolize primary bile acids into secondary bile acids and other derivatives. After breach of the epithelial barrier, or pathogenic invasion, molecules like LPS activate macrophages, DCs, and ILC3, inducing the production of pro-inflammatory cytokines, IFN-γ, TNF-α, IL-6, IL-1β, and IL-17, with an increase in the polarization of M0 macrophages toward a pro-inflammatory M1 phenotype. M1 macrophages and activated DCs therefore induce production of effector T cells (i.e., Th17) and up-regulation of the expression of chemokine CCL2 in the colon, which recalls more monocytes from the blood to the lamina propria of the colon.
Figure 1 Microbiota, bile acid pool, and regulation of intestinal immunity. In a healthy condition, the majority of bile acids are actively reabsorbed by the enterocytes by apical transporter ASBT, and are transported back to the liver through the portal blood, thus limiting BA loss through feces to 3%–5% of daily secreted BAs. BAs reaching the colon are metabolized by the intestinal microbiota which transforms primary bile acids into secondary bile acids and other derivatives which therefore make up the majority of the bile acid pool. BAs through agonism on FXR and GPBAR1 and antagonism on RORγt (inverse agonism) regulate the immune system by inducing a tolerogenic response. The action on these receptors induces the polarization of macrophages and helper T cells towards an anti-inflammatory phenotype, respectively macrophages M2 and Treg, with the up-regulation of IL-10 production, and inhibits the activation of DCs, ILC3, and Th17 by reducing the production of pro-inflammatory cytokines (i.e., IL-6, IL-1β, TNF-α, and IL-17). In patients with IBDs, the alterations of the intestinal epithelium reduce the reabsorption of bile acids and therefore increase the quantity of bile acids that are eliminated with the feces. Furthermore, patients with IBDs have a dysbiosis of the intestinal bacterial flora with a decrease in bacterial species diversity, which strongly decreases the enzymatic capacity of the microbiota, resulting in a lower ability to metabolize primary bile acids into secondary bile acids and other derivatives. After breach of the epithelial barrier, or pathogenic invasion, molecules like LPS activate macrophages, DCs, and ILC3, inducing the production of pro-inflammatory cytokines, IFN-γ, TNF-α, IL-6, IL-1β, and IL-17, with an increase in the polarization of M0 macrophages toward a pro-inflammatory M1 phenotype. M1 macrophages and activated DCs therefore induce production of effector T cells (i.e., Th17) and up-regulation of the expression of chemokine CCL2 in the colon, which recalls more monocytes from the blood to the lamina propria of the colon.CC BY · PubMed Central
Figure 2 Expression and functional role of G-protein bile acid receptor 1 (GPBAR1), Farnesoid-X-receptor (FXR) and RORγt in cells of immunity. Macrophages and dendritic cells (DCs) express GPBAR1 and FXR. T helper cells and ILCs express RORγt. (A) In macrophages, activation of these receptors by bile acids induces a polarization toward the anti-inflammatory M2 phenotype with an upregulation of IL-10 and a downregulation of the pro-inflammatory cytokines. (B) Bile acids, on the other hand, act on the DCs, down-regulating the production of TNF-α and IL-12 and their maturation and differentiation. (C,D) Recently, it was shown that oxo-bile acid derivatives, specifically the 3-oxo-LCA, can bind RORγt by acting as an inverse agonist, decreasing the production of IL-17 in T helper cells and ILCs by reducing the polarization towards the Th17 and ILC3 subtypes.
Figure 2 Expression and functional role of G-protein bile acid receptor 1 (GPBAR1), Farnesoid-X-receptor (FXR) and RORγt in cells of immunity. Macrophages and dendritic cells (DCs) express GPBAR1 and FXR. T helper cells and ILCs express RORγt. (A) In macrophages, activation of these receptors by bile acids induces a polarization toward the anti-inflammatory M2 phenotype with an upregulation of IL-10 and a downregulation of the pro-inflammatory cytokines. (B) Bile acids, on the other hand, act on the DCs, down-regulating the production of TNF-α and IL-12 and their maturation and differentiation. (C,D) Recently, it was shown that oxo-bile acid derivatives, specifically the 3-oxo-LCA, can bind RORγt by acting as an inverse agonist, decreasing the production of IL-17 in T helper cells and ILCs by reducing the polarization towards the Th17 and ILC3 subtypes.CC BY · PubMed Central
Figure 3 Chemical structures. Chemical structures of synthetic derivatives of BAs: (A) BAR501, selective agonist of GPBAR1, and (B) OCA, selective agonist of FXR.
Figure 3 Chemical structures. Chemical structures of synthetic derivatives of BAs: (A) BAR501, selective agonist of GPBAR1, and (B) OCA, selective agonist of FXR.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 103

Metadata

Authors
Biagioli, M., Marchianò, S., Carino, A., Di Giorgio, C., Santucci, L., Distrutti, E., & Fiorucci, S.
Affiliations
  • University of Perugia (IT)
  • Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy
  • Azienda Ospedaliera di Perugia (IT)
Corresponding author
Biagioli, Michele
Venue
Cells
Publisher
MDPI AG
Published
2021-05-21
Volume
10
Issue
6
Pages
1281
ISSN
2073-4409 (ISSN-L)
OpenAlex
W3162040744
Cited by
103
References
108
Citations by year
2026: 23 · 2025: 21 · 2024: 21 · 2023: 23 · 2022: 15
FWCI
1.55
Type
journal article
Language
en
Open access
Locations
  • Cells (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
Keywords
bile acids, bile acid receptors, inflammatory bowel disease, TGR5, farnesoid X receptor, RORγt, gut microbiota, dysbiosis, intestinal inflammation, innate lymphoid cells, Th17 cells, dendritic cells, macrophages, secondary bile acids, host-microbe communication
MeSH terms
Gastrointestinal Microbiome, Receptor, Farnesoid X-Activated, Animals, Bile Acids and Salts, Humans, Immunity, Innate, Inflammatory Bowel Diseases, Receptors, Cytoplasmic and Nuclear, Receptors, G-Protein-Coupled

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.